News from heartware international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

09:00 ET

HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 30, 2015, 07:00 ET

HeartWare International Reports $70.0 Million In First Quarter 2015 Revenue

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 22, 2015, 13:00 ET

HeartWare Schedules First Quarter 2015 Conference Call And Webcast

 HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended March...

Apr 20, 2015, 16:30 ET

Contemporary Results From Commercial HVAD® System Registries Highlighted At ISHLT Meeting In Nice, France

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 16, 2015, 04:20 ET
More than 8,000 advanced heart failure patients around the world have received the HeartWare(R) Ventricular Assist System featuring the HVAD(R) Pump - a small, full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare announced today that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint...

HeartWare Achieves Primary Endpoint In The ENDURANCE Destination Therapy Clinical Trial

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 10, 2015, 19:00 ET

HeartWare Announces Webcasts At The 35th International Society for Heart and Lung Transplantation Annual Meeting

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Apr 09, 2015, 07:30 ET
The HeartWare(R) Ventricular Assist System featuring the HVAD(R) Pump has received approval from Health Canada for commercialization as a bridge to heart transplantation in patients with end-stage heart failure.  More than 8,000 advanced heart failure patients around the world have received this small, full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.

HeartWare International Receives Health Canada Approval For Commercialization Of The HeartWare® Ventricular Assist System As A Bridge To Heart Transplantation

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Mar 04, 2015, 09:00 ET

HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Feb 26, 2015, 07:00 ET

HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Feb 25, 2015, 17:37 ET

HeartWare Presentation At The Raymond James 36th Annual Institutional Investors Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that...

Feb 20, 2015, 16:30 ET

HeartWare International Recalls Certain Older HeartWare® Clinical Trial Controllers

 HeartWare International, Inc. (Nasdaq: HTWR), is issuing a voluntary Urgent Medical Device Recall in the United States related to older...

Feb 13, 2015, 11:00 ET

HeartWare Schedules Fourth Quarter Conference Call And Webcast

 HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended...

Feb 05, 2015, 09:10 ET

HeartWare Presentation At The 2015 Leerink Global Healthcare Conference To Be Webcast

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Jan 13, 2015, 11:05 ET

HeartWare International Announces Preliminary Fourth Quarter 2014 Revenues

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Jan 13, 2015, 08:30 ET

HeartWare Begins HVAD® LATERAL Study, A Clinical Trial Of Advanced Heart Failure Patients Implanted Via Less-Invasive Thoracotomy Technique

 HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Jan 02, 2015, 09:15 ET

HeartWare Presentation At The J.P. Morgan 33rd Annual Healthcare Conference To Be Webcast

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Dec 04, 2014, 12:35 ET

HeartWare Presentation At The Oppenheimer 25th Annual Healthcare Conference To Be Webcast

 HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Nov 13, 2014, 12:11 ET

HeartWare Presentation At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum To Be Webcast

 HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Nov 07, 2014, 09:00 ET

HeartWare Presentation At The Credit Suisse 2014 Healthcare Conference To Be Webcast

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...

Oct 30, 2014, 06:58 ET

HeartWare International Reports $68.6 Million In Third Quarter 2014 Revenue; 25% Increase From Third Quarter 2013

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are...